Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy. (Record no. 30715062)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02129 a2200625 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518091039.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 202006s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1432-0851 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/s00262-020-02534-7 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Voloshin, Tali |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20200630 |
| 245 00 - TITLE STATEMENT | |
| Title | Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Cancer immunology, immunotherapy : CII |
| Date of publication, distribution, etc. | Jul 2020 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1191-1204 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Animals |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents, Immunological |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Apoptosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carcinoma, Hepatocellular |
| General subdivision | immunology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carcinoma, Lewis Lung |
| General subdivision | immunology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Proliferation |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Combined Modality Therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Electric Stimulation Therapy |
| General subdivision | methods |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Immunogenic Cell Death |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Liver Neoplasms |
| General subdivision | immunology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lymphocytes, Tumor-Infiltrating |
| General subdivision | immunology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice, Inbred BALB C |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice, Inbred C57BL |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Programmed Cell Death 1 Receptor |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Tumor Cells, Cultured |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Xenograft Model Antitumor Assays |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kaynan, Noa |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Davidi, Shiri |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Porat, Yaara |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shteingauz, Anna |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schneiderman, Rosa S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zeevi, Einav |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Munster, Mijal |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Blat, Roni |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tempel Brami, Catherine |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cahal, Shay |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Itzhaki, Aviran |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Giladi, Moshe |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kirson, Eilon D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Weinberg, Uri |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kinzel, Adrian |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Palti, Yoram |
| 773 0# - HOST ITEM ENTRY | |
| Title | Cancer immunology, immunotherapy : CII |
| Related parts | vol. 69 |
| -- | no. 7 |
| -- | p. 1191-1204 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1007/s00262-020-02534-7">https://doi.org/10.1007/s00262-020-02534-7</a> |
| Public note | Available from publisher's website |
No items available.